PLA2G3 and cancer: The Pla2g3−/− colon displays significant reduction of several lysophospholipids including lysophophatidic acid (LPA) and lysophosphatidylinositol (LPI) [50], which may promote colon inflammation or cancer through their receptors LPA2 and GPR55, respectively [51,52].